Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityNo recent work listed

Ping Zhang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers

Papers 3

  1. Regulation of tumor microenvironment for pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2021.120680↗
  2. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis. Last author DOI 10.18632/aging.202540↗
  3. Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins. Last author DOI 10.3892/ijo.2018.4315↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhennan Yun · 1 shared paper, 2021 · strength 0.19
  2. Shiquan Li · 1 shared paper, 2021 · strength 0.19
  3. Di Li · 1 shared paper, 2021 · strength 0.13
  4. Xu Huang · 1 shared paper, 2021 · strength 0.13
  5. Miao Yu · 1 shared paper, 2018 · strength 0.10
  6. Di Sun · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.